Company profile: Saegis Pharma
1.1 - Company Overview
Company description
- Provider of medicines in development for behavioral disorders, with a pipeline of treatments for central nervous system diseases involving cognitive dysfunction, including Alzheimerβs disease, mild cognitive impairment, and attention deficit hyperactivity disorder.
Products and services
π
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Saegis Pharma
Vanda Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies focused on central nervous system disorders, developing and commercializing innovative products through clinical and commercial stage programs, including HETLIOZAccess: an expanded access program for Non-24-Hour Sleep-Wake Disorder (Non-24).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Vanda Pharmaceuticals company profile β
Cassava Sciences
HQ: United States
Website
- Description: Provider of an investigational oral drug, Simufilam, for Alzheimerβs disease that stabilizes altered filamin A in the brain; currently in Phase III trials. Offers clinical trial programs (rethinkALZ and refocusALZ) to evaluate efficacy and safety of Simufilam, and an Expanded Access program for patients not eligible for trials with serious or life-threatening conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Cassava Sciences company profile β
Clearmind Medicine
HQ: Canada
Website
- Description: Provider of psychedelic medicine research and development, discovering and developing novel psychedelic-derived therapeutics for under-served health problems. Pipeline includes CMND-100, a MEAI-based oral capsule for Alcohol Use Disorder in Phase I/IIa, and 3-MMC for eating disorders. Holds exclusive worldwide rights to a patent-pending synthesis for addiction and mental disorders and 17 utility patent families (27 granted, 32 pending).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Clearmind Medicine company profile β
Acumen Pharmaceuticals
HQ: United States
Website
- Description: Provider of targeted therapies in development for Alzheimer's disease and related neurodegenerative diseases, including ACU193, a monoclonal antibody targeting toxic soluble amyloid-beta oligomers (AΞ²Os) for early Alzheimer's, and the INTERCEPT-AD Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with mild cognitive impairment or mild dementia due to Alzheimer's.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Acumen Pharmaceuticals company profile β
Interactive Motion Technologies
HQ: United States
Website
- Description: Provider of robotic solutions for patients with neurological conditions, offering evidence-based InMotion Robots developed from medical engineering research at MITβs Newman Laboratory for Biomechanics and Human Rehabilitation, tested by leading medical centers worldwide for 10 years in over 40 studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Interactive Motion Technologies company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Saegis Pharma
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Saegis Pharma
2.2 - Growth funds investing in similar companies to Saegis Pharma
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Saegis Pharma
4.2 - Public trading comparable groups for Saegis Pharma
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β